QLT optimistic about sales of flagship drug, despite decline in revenue (Canadian Business)
March 10th, 2010
QLT Inc. says it’s optimistic about the potential for revenue growth on its Visudyne treatment for age-related blindness despite seeing sales drop
Original post by macular degeneration – Google News
(click on the author/publication link above to see full post)